Joel Greenblatt started to build up the position in Sage Therapeutics in Q1 2021 and continued to invest until Q2 2021. Since then they sold 34.8 Thousand shares. The investor sold all their shares in Q3 2021 and doesn't own any shares in Sage Therapeutics anymore.